Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Tralongo

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Current Urology|July 14, 2023
Feasibility of cabazitaxel in octogenarian prostate cancer patientsPaolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Clinicians' and Patients' Perceptions and Use of the Word "Cured" in Cancer Care: An Italian SurveyPaolo Tralongo, Francesco Cappuccio, Stefania Gori, et al.
Cancer Management and Research|November 7, 2022
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working GroupLuigino Dal Maso, Armando Santoro, Elisabetta Iannelli, et al.
Ecancermedicalscience|June 23, 2020
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical OncologistsLivio Blasi, Roberto Bordonaro, Nicolò Borsellino, et al.
Cancers|November 13, 2025
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell CancerMorena Fasano, Francesco Perri, Mario Pirozzi, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancerGerardo Rosati, Raffaele Addeo, Giuseppe Aprile, et al.
Oncotarget|February 18, 2017
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter surveyMassimiliano Berretta, Chiara Della Pepa, Paolo Tralongo, et al.
Cancer Medicine|October 18, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesca Di Fabio, Gerardo Rosati, et al.
Frontiers in Oncology|May 16, 2020
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian StudyMassimiliano Berretta, Luca Rinaldi, Rosaria Taibi, et al.
Tumori|February 7, 2024
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Current Urology|July 14, 2023
Feasibility of cabazitaxel in octogenarian prostate cancer patientsPaolo Tralongo, Sebastiano Bordonaro, Giuseppe Di Lorenzo, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Clinicians' and Patients' Perceptions and Use of the Word "Cured" in Cancer Care: An Italian SurveyPaolo Tralongo, Francesco Cappuccio, Stefania Gori, et al.
Cancer Management and Research|November 7, 2022
Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working GroupLuigino Dal Maso, Armando Santoro, Elisabetta Iannelli, et al.
Ecancermedicalscience|June 23, 2020
Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical OncologistsLivio Blasi, Roberto Bordonaro, Nicolò Borsellino, et al.
Cancers|November 13, 2025
Retrospective Trial on Cetuximab Plus Radiotherapy in Elderly Patients with Head and Neck Squamous Cell CancerMorena Fasano, Francesco Perri, Mario Pirozzi, et al.
Cancer Chemotherapy and Pharmacology|September 8, 2019
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancerGerardo Rosati, Raffaele Addeo, Giuseppe Aprile, et al.
Oncotarget|February 18, 2017
Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter surveyMassimiliano Berretta, Chiara Della Pepa, Paolo Tralongo, et al.
Cancer Medicine|October 18, 2016
Observational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr StudyCarmine Pinto, Francesca Di Fabio, Gerardo Rosati, et al.
Frontiers in Oncology|May 16, 2020
Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian StudyMassimiliano Berretta, Luca Rinaldi, Rosaria Taibi, et al.
Tumori|February 7, 2024
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Pageof 6